Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Pilot Projects in Aging - Biological & Clinical Aspects of Aging

Université Laval

$50,000.00

MicroRNA loss-of-function tools to study neurodegeneration

EF 2010-11

Résumé
MicroRNAs constitute a recently identified class of small RNA molecules that exist in living cells. These tiny RNAs function to modulate gene expression and therefore protein levels. We have previously shown that some microRNAs are specifically misregulated in the brains of Alzheimer's disease (AD) patients. This observation is particularly interesting as changes in certain protein levels can cause genetic AD. Notably, some of the affected microRNAs in AD brain seem to participate in the development of AD pathology and the survival of neurons, at least in culture. We would like to test this hypothesis experimentally in a living organism. The aim of this project is to develop novel tools aimed at modulating microRNA molecules in the brain of adult mice, which are structurally and functionally similar to humans. We will use normal (wildtype) mouse models to study the involvement of microRNAs in brain maintenance during aging.
Programme
Catalyst Grant: Pilot Projects in Aging - Biological & Clinical Aspects of Aging
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
228749
Name
Hébert Sébastien
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Institute of Aging Pilot Projects
Projecttitle
MicroRNA loss-of-function tools to study neurodegeneration
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Pilot Projects in Aging - Biological & Clinical Aspects of Aging
Keyworddelim
Alzheimer'S Disease; Lentivirus; Loss-Of-Function; Microrna; Mouse Models; Noncoding Rna
Abstract
MicroRNAs constitute a recently identified class of small RNA molecules that exist in living cells. These tiny RNAs function to modulate gene expression and therefore protein levels. We have previously shown that some microRNAs are specifically misregulated in the brains of Alzheimer's disease (AD) patients. This observation is particularly interesting as changes in certain protein levels can cause genetic AD. Notably, some of the affected microRNAs in AD brain seem to participate in the development of AD pathology and the survival of neurons, at least in culture. We would like to test this hypothesis experimentally in a living organism. The aim of this project is to develop novel tools aimed at modulating microRNA molecules in the brain of adult mice, which are structurally and functionally similar to humans. We will use normal (wildtype) mouse models to study the involvement of microRNAs in brain maintenance during aging.
Competitiondate
201009
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hébert, Sébastien
Approvedterm
1 an 0 mois
Cihrcontribution2
Institute of Aging~ $50,000~ $0~